← FDA Drug Approvals (Drugs@FDA)

TAZVERIK

NDA · New Drug Application · Sponsor: EPIZYME INC · Approved 2020-01-23

Drug application

FDA Application #

NDA211723

Application type

New Drug Application

Brand name

TAZVERIK

Generic name

TAZEMETOSTAT

Active ingredients

TAZEMETOSTAT HYDROBROMIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

EPIZYME INC

Manufacturer

Epizyme, Inc.

First approval

2020-01-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown